Position in JNJ
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$24,150,183
-$25,933,579 QoQ
Shares Held
98,798
-59.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MUFG Securities EMEA plc holds $423,932,325 across 10 Drug Manufacturers - General names. JNJ ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
863,980 | $170,394,135 | |
| 2 | ABBV |
AbbVie Inc.
|
432,445 | $94,052,463 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
521,862 | $72,731,906 | |
| 4 | LLY |
ELI LILLY & Co
|
32,487 | $29,880,567 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
98,798 | $24,150,183 | |
| 6 | MRK |
Merck & Co., Inc.
|
101,752 | $12,239,748 | |
| 7 | AMGN |
Amgen Inc
|
22,085 | $7,770,607 | |
| 8 | PFE |
Pfizer Inc
|
233,159 | $6,547,104 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,150,183 | 98,798 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $50,083,762 | 242,009 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,547,305 | 46,097 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,086,052 | 7,110 | Shares | Sole | 2025-10-07 | |
| 2024-12-31 | $9,689,540 | 67,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $22,040,160 | 136,000 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $27,683 | 175 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $47,049,429 | 300,175 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $110,271 | 708 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $106,263 | 642 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $229,090 | 1,478 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $57,587 | 326 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $161,072 | 986 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $61,418 | 346 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $68,367,633 | 423,329 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $243,045,699 | 1,475,329 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $162,568,446 | 989,160 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $255,452,920 | 1,623,160 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $221,873,630 | 1,490,285 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $211,852,907 | 1,506,456 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $87,898,668 | 670,317 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||